Note, however, that RWPE1 (a healthy prostate cell line with similar TLK1 expression [117]) was insensitive to J54, suggesting that J54 may be a more targeted anti-cancer agent or the TLK1-NEK1 axis may remain critical even for the CRPC cells. Here, TLK1 is linked to cancer.